What is the role of genetic studies in the diagnosis of pseudomesotheliomatous carcinoma?

Updated: Dec 25, 2019
  • Author: Joseph F Tomashefski, Jr, MD; more...
  • Print


There are few studies of molecular or genetic alterations in pseudomesotheliomatous lung adenocarcinoma. In 4 cases, Pardo et al reported a median of 15 chromosomal imbalances per case using a comparative genomic hybridization technique. [57] In this study, the most frequent aberrations were gains on chromosome regions 1q, 3q, 5p, 8q, 16p, and 18q and losses in 17p11-13 and 17q22-q25. All cases showed a characteristic association between the gains on 16p and those on 18q. [57]

Further molecular and genetic studies are required to discern if there are consistent molecular markers of pseudomesotheliomatous adenocarcinoma that distinguish it from usual non–small cell lung carcinoma or malignant mesothelioma.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!